Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005227235
Thu, 06.03.2025
Biotest AG
Ad hoc NOTICE
Notification pursuant to Art. 17 EU Market Abuse Regulation (MAR)
CFO Martin Möller to leave Biotest as planned at the end of his contract. Position of CFO to be filled in the near future
Dreieich, Germany, 6 March 2025. The Board of Management of Biotest AG announces that Chief Financial Officer Martin Möller will terminate his [ … ]
Wed, 26.02.2025
Biotest AG
Ad-hoc RELEASE
Announcement according to Article 17 European Market Abuse Regulation (MAR)
Biotest publishes preliminary business figures - 2024 forecasts partially exceeded
Dreieich, 26 February 2025: According to preliminary and unaudited figures, the Biotest Group generated revenue of € 726.2 million in the 2024 financial year, compared [ … ]
Thu, 09.01.2025
Biotest AG
PRESS RELEASE
Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA)
Biotest's fibrinogen aims to fulfill a high unmet medical need for additional fibrinogen to treat acquired fibrinogen deficiency
US submission follows EU application for marketing authorizatio [ … ]